<DOC>
	<DOCNO>NCT00978536</DOCNO>
	<brief_summary>In multiple sclerosis ( MS ) sub cortical cognitive impairment frequently report . Nevertheless , cortical cognitive trouble , hippocampic memory trouble describe . Besides inflammatory damage , early cortical degenerative damage well know . In neurodegenerative disease , three biomarkers cerebro spinal fluid ( CSF ) , reflect lesional mechanism , measure : beta amyloid peptide , tau total protein , phospho tau protein . Preliminary study show increased level tau MS. No study compare cognitive impairment biomarkers CSF.The aim study measure CSF MS patient three biomarkers ( beta amyloid peptide , tau total phosphotau ) order establish correlation profile biomarkers pattern cognitive trouble , cortical subcortical.The possibility show , MS patient memory hippocampic trouble , profile biomarkers close one encountered AD , could argue support degenerative hypothesis MS lead discus interest use AD treatment MS .</brief_summary>
	<brief_title>A Monocenter , Cross-sectional Study Compare Different Type Cognitive Impairment Multiple Sclerosis Patients Cerebrospinal Fluid Biomarkers ( Beta Amyloid , Total Tau Protein Tau-phosphorylated Protein ) .</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>Groups 1 2 patient MS EDSS &lt; 7 Group 3 patient first clinical inflammatory symptom Pregnant take contraceptive Contraindication lumbar puncture Contraindication NMR</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Multiple sclerosis</keyword>
	<keyword>cognitive deterioration</keyword>
	<keyword>biomarkers</keyword>
	<keyword>cerebrospinal fluid</keyword>
	<keyword>Alzheimer disease</keyword>
</DOC>